Ge Li
Founder & ChairmanDr. Ge Li, Ph.D., served as a Member of Strategic Advisory Board at Longwood Fund till June 2024. He serves as the President at WuXi AppTec Co., Ltd. since May 21, 2020. Dr. Li serves as Chief Executive Officer of WuXi AppTec Co., Ltd. Dr. Li is a Co-founder of Hua Medicine (Shanghai) Ltd. Dr. Li co-founded WuXi AppTec Co., Ltd. in 2000 and has been its Executive Chairman since 2004. Dr. Li is Founding Partner and Chairman of 6 Dimensions Capital (also known as, Wuxi Healthcare Ventures) since May 2017. He co-founded WuXi AppTec, Inc in 2000 and has been its Chairman and Chief Executive Officer since 2000. Dr. Li co-founded WuXi PharmaTech (Cayman) Inc. in 2000 and has been its Chairman since 2004 and also has been its Chief Executive Officer since 2000. He is a Co-Owner of Ge Li & Ning Zhao Trust. Dr. Li has been an Advisor for WI Harper Group since September 26, 2010. He was the founder of Pharmacopeia, Inc. Dr. Li began his career in 1993 as one of the Founding Scientists at Pharmacopeia, Inc. and held a series of scientific and management leadership positions. Dr. Li spent many years with Pharmacopeia. He served as Director at Hua Medicine (Shanghai) Ltd. until December 26, 2018. He has been the Chairman and Chief Executive Officer of WuXi AppTec since December 2000. Dr. Li founded WuXi Biologics (Cayman) Inc. He has been a Non-executive Director & Chairman of WuXi Biologics (Cayman) Inc. since February 2, 2014. He served as a Non-Executive Director of JW (Cayman) Therapeutics Co. Ltd until March 22, 2020. He served as a Director of Adagene (Suzhou) Limited, WuXi AppTec Co., Ltd. since March 01, 2017, Phagelux, Inc, WuXi PharmaTech (Cayman) Inc and WuXi AppTec, Inc. He serves as Member of Advisory Board at MDL Information Systems GmbH. Dr. Li is a Co-Inventor on a number of important patents pertaining to medicinal chemistry and ombinatorial chemistry. He has published numerous articles in peer-reviewed professional journals. Dr. Li's achievements have won him numerous prestigious awards and honors including the Most Innovative Leader of the Chinese Enterprises of 2008 and 2012 Boston Biotech Chief Executive Officers Conference Life Achievement Award. He was named as one of the 2011 China Healthcare Industry Innovative Leaders, Top Contributors to China's Outsourcing Industry, 2011 BayHelix Lifetime Achievement Award, San Diego Bio-Pharma Achievement Award 2010, The 60 Most Influential People during 60 Years Pharmaceutical Development in China, the 2007 China Top 10 Influential Entrepreneurs, Ernst & Young Entrepreneur of the Year China 2007 Award, 2006 China Top Ten Talents (Science & Technology) Award, Forbes 25 Notable Chinese Americans and many more. In 2005, Dr. Li was featured on the cover page of Red Herring magazine's August 1st issue and honored with Distinguished Entrepreneur Award from Overseas Chinese Affairs Office of The State Council of People's Republic of China, receiving this prestigious award at the Great Hall of the People in Beijing on September 29, 2005. He was named as One of the 25 most influential people in biopharma in 2015. Dr. Li holds a Master's degree and Ph.D. degree in Organic Chemistry from Columbia University in 1993 & 1994 and a B.S. in Chemistry from Peking University in 1989.
Positions
- Company NameWuXi Biologics (Cayman) Inc.Stock Code02269PositionFounder & ChairmanRelated SecuritiesColleagues
- ZCZhisheng ChenCEO & Executive Director
- XGXuejun GuCTO, Chief Client Officer, EVP of Global Biologics Development Department & Executive Director
- MTMing TuCFO & Executive VP
- LYLihua YuCOO & Senior VP
- WRWilliam Robert KellerIndependent Non-Executive Director
- JPJackson Peter TaiIndependent Non-Executive Director
- Company NameWuXi AppTec Co., Ltd.Stock Code02359PositionCo-Founder, Executive Chairman, President & CEORelated Securities
